Anti-Neutrophil Cytoplasmic Antibodies (Formalin-fixed)
FDA UDIEUDAMEDClass II (US FDA UDI)
Identity
- Trade Name
- Anti-Neutrophil Cytoplasmic Antibody (Formalin Fixed) EUDAMEDAnti-Neutrophil Cytoplasmic Antibodies (Formalin-fixed) FDA UDI
- Generic Name
- Multiple anti-neutrophil cytoplasmic antibody (ANCA) IVD, kit, fluorescent immunoassay FDA UDI
- Device Name
- Anti-Neutrophil Cytoplasmic Antibody (Formalin Fixed) EUDAMEDStandard IFA methods allow for the observation of several different patterns. Two patterns that have been well defined are C-ANCA and P-ANCA. The P-ANCA pattern shows an uneven granular, staining of the cytoplasm. During the 2nd International ANCA Workshop it was agreed that these two different patterns should be used to subclassify the antibodies. Anti-neutrophil cytoplasmic antibody (ANCA)antibody detection by IFA methods has been a useful aid in the assessment of patient diagnosis, and to a certain extent their prognosis and response to therapy. Although there has been much work done with the IFA ANCA, the availability of an MPO-specific enzyme immunoassay (EIA) test has further enhanced the overall picture. The use of EIA and IFA together allows for the best possible patient assessment. The MPO and PR3 EIA allows for a very quick qualitative as well as quantitative report. FDA UDI
- Model / Reference
- A060PL EUDAMEDFDA UDI
- Description
- Standard IFA methods allow for the observation of several different patterns. Two patterns that have been well defined are C-ANCA and P-ANCA. The P-ANCA pattern shows an uneven granular, staining of the cytoplasm. During the 2nd International ANCA Workshop it was agreed that these two different patterns should be used to subclassify the antibodies. Anti-neutrophil cytoplasmic antibody (ANCA)antibody detection by IFA methods has been a useful aid in the assessment of patient diagnosis, and to a certain extent their prognosis and response to therapy. Although there has been much work done with the IFA ANCA, the availability of an MPO-specific enzyme immunoassay (EIA) test has further enhanced the overall picture. The use of EIA and IFA together allows for the best possible patient assessment. The MPO and PR3 EIA allows for a very quick qualitative as well as quantitative report. FDA UDI
Identifiers
- Catalog Number
- A060PL FDA UDI
- Primary DI / UDI-DI
- D-A060PLX4 EUDAMED00845533001991 FDA UDI
- Basic UDI-DI
- B-A060PLX4 EUDAMED
- 510(k) Number
- K962360 FDA UDI
- FDA Product Code
- MOB FDA UDI
- EMDN Code
- W0102100401 ANCA SCREENING EUDAMED
- GMDN Term
- Multiple anti-neutrophil cytoplasmic antibody (ANCA) IVD, kit, fluorescent immunoassay FDA UDI
Classification
- Device Class
- Class IVD General EUDAMEDClass II FDA UDI
- Regulation Number
- 866.5660 FDA UDI
- Market of Registration
- France EUDAMED
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
Single Use
Yes
Implantable
No
Contains Latex
No
Human Tissues
Yes
Animal Tissues
Yes
Microbial Substances
Yes
Reagent
Yes
Self Testing
No
Near-Patient Testing
No
Professional Testing
Yes
Companion Diagnostics
No
Surgical Instrument
No
Prescription Use
Yes
Over-the-Counter
No
Convenience Kit
Yes
Combination Product
No
HCT/P
No
Premarket Exempt
No
Lot / Batch Number
Yes
Serial Number
No
Expiration Date
Yes
Manufacturing Date
No
Category: Multiple anti-neutrophil cytoplasmic antibody (ANCA) IVD, kit, fluorescent immunoassay
Anti-Neutrophil Cytoplasmic Antibodies (Formalin-fixed) by Zeus Scientific, Inc. — Class II — IVDD, FDA UDI — listed in FDA GUDID, EUDAMED
Similar devices
Also classified as Multiple anti-neutrophil cytoplasmic antibody (ANCA) IVD, kit, fluorescent immunoassay.
- IFA: Granulocyte Mosaic 13 EUROPattern — EUROIMMUN Medizinische Labordiagnostika AG · Class II
- IFA: Granulocyte Mosaic 13 — EUROIMMUN Medizinische Labordiagnostika AG · Class II
- IMMCO DIAGNOSTICS — Immco Diagnostics, Inc.
- ANCA Test System — IMMUNO CONCEPTS INC
- ANCA-L Test System — IMMUNO CONCEPTS INC
- IFA: Granulocyte Mosaic 2 — EUROIMMUN Medizinische Labordiagnostika AG · Class II
- ANCA Test System — IMMUNO CONCEPTS INC
- IFA: Granulocyte Mosaic 13 EUROPattern — EUROIMMUN Medizinische Labordiagnostika AG · Class II
Cleared under the same submission
Authorization Coverage (2 countries)
Regulatory Authorizations
IVDD
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | IVDD | — | Class II | Unknown |
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Zeus Scientific, Inc.
Sources (2)
- FDA UDI 58bc979a-ab3e-4165-a78c-951a08095e65 36 fields · synced Jun 18, 2026
- EUDAMED 2f9522fe-991b-4b97-b820-e5dbb8f3d749 61 fields · synced Jun 18, 2026